252 related articles for article (PubMed ID: 25889470)
1. Health gains and financial risk protection afforded by public financing of selected interventions in Ethiopia: an extended cost-effectiveness analysis.
Verguet S; Olson ZD; Babigumira JB; Desalegn D; Johansson KA; Kruk ME; Levin CE; Nugent RA; Pecenka C; Shrime MG; Memirie ST; Watkins DA; Jamison DT
Lancet Glob Health; 2015 May; 3(5):e288-96. PubMed ID: 25889470
[TBL] [Abstract][Full Text] [Related]
2. Health gains and financial risk protection: an extended cost-effectiveness analysis of treatment and prevention of diarrhoea in Ethiopia.
Pecenka CJ; Johansson KA; Memirie ST; Jamison DT; Verguet S
BMJ Open; 2015 May; 5(4):e006402. PubMed ID: 25941175
[TBL] [Abstract][Full Text] [Related]
3. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis.
Verguet S; Murphy S; Anderson B; Johansson KA; Glass R; Rheingans R
Vaccine; 2013 Oct; 31(42):4902-10. PubMed ID: 23871824
[TBL] [Abstract][Full Text] [Related]
4. Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis.
Johansson KA; Memirie ST; Pecenka C; Jamison DT; Verguet S
PLoS One; 2015; 10(12):e0142691. PubMed ID: 26650078
[TBL] [Abstract][Full Text] [Related]
5. Task-sharing or public finance for the expansion of surgical access in rural Ethiopia: an extended cost-effectiveness analysis.
Shrime MG; Verguet S; Johansson KA; Desalegn D; Jamison DT; Kruk ME
Health Policy Plan; 2016 Jul; 31(6):706-16. PubMed ID: 26719347
[TBL] [Abstract][Full Text] [Related]
6. Health gains and financial risk protection afforded by public financing of selected malaria interventions in Ethiopia: an extended cost-effectiveness analysis.
Assebe LF; Kwete XJ; Wang D; Liu L; Norheim OF; Jbaily A; Verguet S; Johansson KA; Tolla MT
Malar J; 2020 Jan; 19(1):41. PubMed ID: 31973694
[TBL] [Abstract][Full Text] [Related]
7. Health Gains and Financial Protection Provided by the Ethiopian Mental Health Strategy: an Extended Cost-Effectiveness Analysis.
Johansson KA; Strand KB; Fekadu A; Chisholm D
Health Policy Plan; 2017 Apr; 32(3):376-383. PubMed ID: 27935798
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
Megiddo I; Colson AR; Nandi A; Chatterjee S; Prinja S; Khera A; Laxminarayan R
Vaccine; 2014 Aug; 32 Suppl 1():A151-61. PubMed ID: 25091670
[TBL] [Abstract][Full Text] [Related]
9. Effects of public financing of essential maternal and child health interventions across wealth quintiles in Nigeria: an extended cost-effectiveness analysis.
Mao W; Watkins D; Sabin ML; Huang K; Langlois E; Ogundeji Y; Fogstad H; Schäferhoff M; Yamey G; Ogbuoji O
Lancet Glob Health; 2023 Apr; 11(4):e597-e605. PubMed ID: 36925179
[TBL] [Abstract][Full Text] [Related]
10. Addressing child health inequity through case management of under-five malaria in Nigeria: an extended cost-effectiveness analysis.
Dasgupta RR; Mao W; Ogbuoji O
Malar J; 2022 Mar; 21(1):81. PubMed ID: 35264153
[TBL] [Abstract][Full Text] [Related]
11. Health gains and financial protection from human papillomavirus vaccination in Ethiopia: findings from a modelling study.
Portnoy A; Sweet S; Desalegn D; Memirie ST; Kim JJ; Verguet S
Health Policy Plan; 2021 Jun; 36(6):891-899. PubMed ID: 33942850
[TBL] [Abstract][Full Text] [Related]
12. Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis.
Verguet S; Laxminarayan R; Jamison DT
Health Econ; 2015 Mar; 24(3):318-32. PubMed ID: 24497185
[TBL] [Abstract][Full Text] [Related]
13. Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study.
De Neve JW; Andriantavison RL; Croke K; Krisam J; Rajoela VH; Rakotoarivony RA; Rambeloson V; Schultz L; Qamruddin J; Verguet S
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007002. PubMed ID: 30589847
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa: an extended cost-effectiveness analysis.
Watkins DA; Olson ZD; Verguet S; Nugent RA; Jamison DT
Health Policy Plan; 2016 Feb; 31(1):75-82. PubMed ID: 25841771
[TBL] [Abstract][Full Text] [Related]
15. Who benefits most from extending financial protection for cataract surgery in Vietnam? An extended cost-effectiveness analysis of small incision surgery.
Essue BM; Jan S; Phuc HT; Dodson S; Armstrong K; Laba TL
Health Policy Plan; 2020 May; 35(4):399-407. PubMed ID: 32031615
[TBL] [Abstract][Full Text] [Related]
16. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
[TBL] [Abstract][Full Text] [Related]
17. Providing universal access to modern contraceptive methods: An extended cost-effectiveness analysis of meeting the demand for modern contraception in Ethiopia.
Enden MR; Tolla MT; Norheim OF
Soc Sci Med; 2021 Jul; 281():114076. PubMed ID: 34116422
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
